AR056874A1 - Derivados de 6- heteroarilpiridoindolona, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de 6- heteroarilpiridoindolona, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- AR056874A1 AR056874A1 ARP060104538A ARP060104538A AR056874A1 AR 056874 A1 AR056874 A1 AR 056874A1 AR P060104538 A ARP060104538 A AR P060104538A AR P060104538 A ARP060104538 A AR P060104538A AR 056874 A1 AR056874 A1 AR 056874A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- hydrogen atom
- alkyl group
- nr8r9
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Proceso de preparacion y aplicacion terapéutica en proliferacion de células tumorales. Reivindicacion 1: Compuesto que responde a la formula (1), en la que R1 representa un átomo de hidrogeno, un grupo alquilo C1-4, CN, CF3 o CHF2; R2 representa un átomo de hidrogeno o un grupo alquilo C1-4; R3 representa un fenilo no sustituido o sustituido uno o varias veces con sustituyentes elegidos de manera independiente entre un átomo de halogeno, un grupo alquilo C1-4, o un grupo alcoxi C1-4; R4 representa un radical heterocíclico elegido entre los del grupo de formulas (2); R5 representa un átomo de hidrogeno, un átomo de halogeno, un grupo alquilo C1-4 o un grupo alcoxi C1-4; R6 se elige entre un átomo de hidrogeno, un grupo -SO2-R12, un grupo alquilo C1-6, mono o perfluoro alquilo C1-6, un grupo -(CH2)n-NR8R9, un grupo -(CH2)n-NH-CO-alquilo C1-4, un grupo -(CH2)n-NH-SO2-alquilo C1-4, un grupo -(CH2)n-NH-(CH2)m-NR8R9, un grupo -(CH2)n -NH-(CH2)m-OR10, un grupo -(CH2)n-O-(CH2)m - NR8R9, un grupo -(CH2)n-O-(CH2)m-O-alquilo C1-4, un grupo -(CH2)nHal, un grupo -alquilo C1-6-O-R10, un grupo -CO2-(CH2)m-O-R10, un grupo -(CH2)n-COOR11; un grupo alquilcarbonilo C1-6-, mono o perfluoro alquilcarbonilo C1-6-, CO-NH-R10, -CO-alquilo C1-6-O-alquilo C1-4; R7 se elige entre el átomo de hidrogeno, un grupo alquilo C1-6, mono o perfluoro alquilo C1-6, un grupo -(CH2)n-NR8R9, un grupo -(CH2)n-NH-CO-alquilo C1-4, un grupo -(CH2)n-NH-SO2-alquilo C1-4, un grupo -(CH2)n-NH-(CH2)m-NR8R9, un grupo -(CH2)n-NH-(CH2)m-OR10, un grupo -(CH2)n-O-(CH2)m-NR8R9, un grupo -(CH2)n-O-(CH2)m-O-alquilo C1-4, un grupo -(CH2)nHal, un grupo -alquilo C1-6-O-R10, un grupo -CO2-(CH2)m -O-R10, un grupo -(CH2)n-COOR11; un grupo alquilcarbonilo C1-6-, mono o perfluoro alquilcarbonilo C1-6-, CO-NH-R10, -CO-alquilo C1-6-O-alquilo C1-4; R8 y R9 representan cada uno de manera independiente el uno del otro un átomo de hidrogeno o un grupo alquilo C1-4; o bien R8 y R9 juntos con el átomo de nitrogeno al que están unidos constituyen un radical heterocíclico elegido entre pirrolidin-1-ilo, piperidin-1-ilo, morfolin-4-ilo o piperacinilo sustituido opcionalmente en su segundo átomo de nitrogeno; R10 representa un átomo de hidrogeno, un grupo alquilo C1-4, un grupo alquilcarbonilo C1-4-, un grupo cicloalquilcarbonilo C3-6-, un grupo cicloalquilo C3-6alquilcarbonilo C1-4-, un grupo cicloalquilo C3-6, un grupo heterocicloaIquilo C5-6, un grupo mono o perfluoro alquilo C1-6 o un grupo cicloalquilo C3- 6alquilo C1-4-; R11 representa un átomo de hidrogeno o un grupo alquilo C1-6; R12 representa un grupo alquilo C1-6, un grupo mono o perfluoro alquilo C1-6, un grupo cicloalquilo, un grupo cicloalquilalquilo o un grupo alquilo C1-6-O-alquilo C1-4-; m es 1 o 2; n es 0, 1 o 2; Hal representa un átomo de halogeno; en el estado de base o de sal de adicion a un ácido, así como en el estado de hidrato o de solvato.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0510730A FR2892416B1 (fr) | 2005-10-20 | 2005-10-20 | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR056874A1 true AR056874A1 (es) | 2007-10-31 |
Family
ID=35953891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060104538A AR056874A1 (es) | 2005-10-20 | 2006-10-18 | Derivados de 6- heteroarilpiridoindolona, su preparacion y su aplicacion en terapeutica |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US8063061B2 (es) |
| EP (1) | EP1940840B1 (es) |
| JP (1) | JP2009512666A (es) |
| KR (1) | KR20080057300A (es) |
| CN (1) | CN101312970A (es) |
| AR (1) | AR056874A1 (es) |
| AT (1) | ATE474840T1 (es) |
| AU (1) | AU2006303210A1 (es) |
| BR (1) | BRPI0617684A2 (es) |
| CA (1) | CA2625502C (es) |
| CR (1) | CR9873A (es) |
| CY (1) | CY1110891T1 (es) |
| DE (1) | DE602006015675D1 (es) |
| DK (1) | DK1940840T3 (es) |
| DO (1) | DOP2006000225A (es) |
| EA (1) | EA014873B1 (es) |
| EC (1) | ECSP088370A (es) |
| ES (1) | ES2348745T3 (es) |
| FR (1) | FR2892416B1 (es) |
| GT (1) | GT200600462A (es) |
| HR (1) | HRP20100572T1 (es) |
| IL (1) | IL190519A0 (es) |
| MA (1) | MA29961B1 (es) |
| NO (1) | NO20082226L (es) |
| PE (1) | PE20070591A1 (es) |
| PL (1) | PL1940840T3 (es) |
| PT (1) | PT1940840E (es) |
| SI (1) | SI1940840T1 (es) |
| TN (1) | TNSN08161A1 (es) |
| TW (1) | TW200734336A (es) |
| UY (1) | UY29879A1 (es) |
| WO (1) | WO2007045758A1 (es) |
| ZA (1) | ZA200803445B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823975B1 (fr) | 2001-04-27 | 2003-05-30 | Sanofi Synthelabo | Nouvelle utilisation de pyridoindolone |
| FR2846329B1 (fr) | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique |
| US7456193B2 (en) | 2002-10-23 | 2008-11-25 | Sanofi-Aventis | Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics |
| FR2869316B1 (fr) | 2004-04-21 | 2006-06-02 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique. |
| SG11201407625WA (en) * | 2012-05-17 | 2014-12-30 | Genentech Inc | Process for making amino acid compounds |
| US9802920B2 (en) | 2013-12-13 | 2017-10-31 | Hoffman-La Roche Inc. | Inhibitors of bruton's tyrosine kinase |
| CN105793252B (zh) | 2013-12-13 | 2018-01-30 | 豪夫迈·罗氏有限公司 | 布鲁顿氏酪氨酸激酶抑制剂 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1268772A (en) | 1968-03-15 | 1972-03-29 | Glaxo Lab Ltd | NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME |
| US4263304A (en) * | 1978-06-05 | 1981-04-21 | Sumitomo Chemical Company, Limited | 7 H-indolo[2,3-c]isoquinolines |
| SU833971A1 (ru) | 1979-07-10 | 1981-05-30 | Ленинградский Химико-Фармацевтическийинститут | Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ |
| FR2595701B1 (fr) * | 1986-03-17 | 1988-07-01 | Sanofi Sa | Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant |
| DE69535703T2 (de) * | 1994-04-13 | 2009-02-19 | The Rockefeller University | AAV-vermittelte Zufuhr von DNA an Zellen des Nervensystems |
| DE19502753A1 (de) * | 1995-01-23 | 1996-07-25 | Schering Ag | Neue 9H-Pyrido[3,4-b]indol-Derivate |
| FR2765581B1 (fr) | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique |
| FR2765582B1 (fr) | 1997-07-03 | 1999-08-06 | Synthelabo | Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique |
| US6291473B1 (en) | 1998-04-02 | 2001-09-18 | Neurogen Corporation | Aminoalkyl substituted 5,6,7,8-tetrahydro-9H-pyridino [2, 3-B] indole and 5,6,7,8-tetrahydro-9H-pyrimidino [4, 5-B] indole derivatives: CRF1 specific ligands |
| IT1313592B1 (it) | 1999-08-03 | 2002-09-09 | Novuspharma Spa | Derivati di 1h-pirido 3,4-b indol-1-one. |
| US20020156016A1 (en) * | 2001-03-30 | 2002-10-24 | Gerald Minuk | Control of cell growth by altering cell membrane potentials |
| FR2823975B1 (fr) | 2001-04-27 | 2003-05-30 | Sanofi Synthelabo | Nouvelle utilisation de pyridoindolone |
| US7456193B2 (en) * | 2002-10-23 | 2008-11-25 | Sanofi-Aventis | Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics |
| FR2846330B1 (fr) * | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique |
| FR2846329B1 (fr) * | 2002-10-23 | 2004-12-03 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique |
| FR2869316B1 (fr) * | 2004-04-21 | 2006-06-02 | Sanofi Synthelabo | Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique. |
-
2005
- 2005-10-20 FR FR0510730A patent/FR2892416B1/fr not_active Expired - Fee Related
-
2006
- 2006-10-05 PE PE2006001217A patent/PE20070591A1/es not_active Application Discontinuation
- 2006-10-16 DO DO2006000225A patent/DOP2006000225A/es unknown
- 2006-10-17 DE DE602006015675T patent/DE602006015675D1/de active Active
- 2006-10-17 GT GT200600462A patent/GT200600462A/es unknown
- 2006-10-17 ZA ZA200803445A patent/ZA200803445B/xx unknown
- 2006-10-17 AU AU2006303210A patent/AU2006303210A1/en not_active Abandoned
- 2006-10-17 KR KR1020087009373A patent/KR20080057300A/ko not_active Application Discontinuation
- 2006-10-17 EP EP06830970A patent/EP1940840B1/fr active Active
- 2006-10-17 PT PT06830970T patent/PT1940840E/pt unknown
- 2006-10-17 WO PCT/FR2006/002330 patent/WO2007045758A1/fr active Application Filing
- 2006-10-17 ES ES06830970T patent/ES2348745T3/es active Active
- 2006-10-17 AT AT06830970T patent/ATE474840T1/de active
- 2006-10-17 CA CA2625502A patent/CA2625502C/fr not_active Expired - Fee Related
- 2006-10-17 SI SI200630800T patent/SI1940840T1/sl unknown
- 2006-10-17 CN CNA2006800433247A patent/CN101312970A/zh active Pending
- 2006-10-17 DK DK06830970.7T patent/DK1940840T3/da active
- 2006-10-17 PL PL06830970T patent/PL1940840T3/pl unknown
- 2006-10-17 EA EA200801123A patent/EA014873B1/ru not_active IP Right Cessation
- 2006-10-17 JP JP2008536081A patent/JP2009512666A/ja not_active Withdrawn
- 2006-10-17 BR BRPI0617684-4A patent/BRPI0617684A2/pt not_active IP Right Cessation
- 2006-10-18 AR ARP060104538A patent/AR056874A1/es unknown
- 2006-10-19 TW TW095138582A patent/TW200734336A/zh unknown
- 2006-10-20 UY UY29879A patent/UY29879A1/es unknown
-
2008
- 2008-03-30 IL IL190519A patent/IL190519A0/en unknown
- 2008-04-08 CR CR9873A patent/CR9873A/es not_active Application Discontinuation
- 2008-04-09 US US12/100,079 patent/US8063061B2/en not_active Expired - Fee Related
- 2008-04-10 TN TNP2008000161A patent/TNSN08161A1/en unknown
- 2008-04-15 EC EC2008008370A patent/ECSP088370A/es unknown
- 2008-05-14 NO NO20082226A patent/NO20082226L/no not_active Application Discontinuation
- 2008-05-19 MA MA30945A patent/MA29961B1/fr unknown
-
2010
- 2010-10-13 CY CY20101100910T patent/CY1110891T1/el unknown
- 2010-10-19 HR HR20100572T patent/HRP20100572T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR056874A1 (es) | Derivados de 6- heteroarilpiridoindolona, su preparacion y su aplicacion en terapeutica | |
| AR049543A1 (es) | Derivados de la 1-amino-ftalazina, su preparacion y su aplicacion en terapeutica | |
| AR057810A1 (es) | Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo y composicion farmaceutica | |
| AR049739A1 (es) | Derivados de aril-piridina | |
| AR057131A1 (es) | Derivados de purina como inmunomodulador | |
| AR086546A1 (es) | Derivados de 7h-purin-8(9h)-ona como inhibidores de jak | |
| AR054857A1 (es) | Derivados de n- (heteroaril)-1- heteroarilquil-1 h - indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica | |
| HRP20080608T3 (en) | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors | |
| TW200833329A (en) | 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| AR045687A1 (es) | Macrociclos derivados de la quinazolina, procesos de preparacion y composiciones farmaceuticas que los contienen | |
| CO6351734A2 (es) | Compuestos de amida utiles en terapia | |
| AR064937A1 (es) | Derivados de n-(heteroaril)-1-heteroaril-1h-indol-2-carboxamidas, su preparacion y su aplicacion en terapeutica | |
| AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
| AR060604A1 (es) | Nuevos arilamino n- heteroarilos como inhibidores de mek | |
| AR068846A1 (es) | Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer | |
| AR049784A1 (es) | Derivados sustituidos de morfolina y tiomorfolina | |
| EA200601177A1 (ru) | Пиридо- и пиримидопиримидиновые производные в качестве антипролиферативных агентов | |
| AR046982A1 (es) | Derivados de 1-piperazin- y 1-homopiperazin-carboxilatos, su preparacion y su aplicacion en terapeutica | |
| NO20072053L (no) | Nye bis-azaindolderivater, fremstilling og farmasoytisk anvendelse derav som kinaseinhibitorer | |
| AR044906A1 (es) | Derivados de difenilpiridina, su preparacion y su aplicacion en terapeutica | |
| AR065863A1 (es) | Derivados de imidazolidinona | |
| AR049845A1 (es) | Derivados de pirido-pirimidina, su preparacion y su aplicacion en terapeutica | |
| MX2010013939A (es) | Derivados de n-oxido pirazina sustituidos. | |
| AR062499A1 (es) | Derivados de n-fenil pirazol y piridil pirazoles, composiciones farmaceuticas que los contienen y usos como agentes antiagregantes plaquetarios y antitromboticos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |